Transparency of reporting in molecular diagnostics.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022.International journal of molecular sciences · 2023
   Article
2. qPCR primer design revisited.Biomolecular detection and quantification · 2017
   Review
3. Improving the reliability of peer-reviewed publications: We are all in it together.Biomolecular detection and quantification · 2016
   Article
4. The reproducibility of biomedical research: Sleepers awake!Biomolecular detection and quantification · 2014
   Review
5. How to make Mathematics Biology's next and better microscope.Biomolecular detection and quantification · 2014
   Article
6. The transcriptomes of the crucian carp complex (Carassius auratus) provide insights into the distinction between unisexual triploids and sexual diploids.International journal of molecular sciences · 2014
   Article
7. High expression of SOX2 is associated with poor prognosis in patients with salivary gland adenoid cystic carcinoma.International journal of molecular sciences · 2014
   Article
8. The need for transparency and good practices in the qPCR literature.Nature methods · 2013
   Article
9. The effect on proliferation and differentiation of cementoblast by using sclerostin as inhibitor.International journal of molecular sciences · 2013
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as